Results 61 to 70 of about 1,518 (174)

Phenotypic expression and founder effect of PANK2 c.1583C>T (p.T528M) mutation in Serbian pantothenate kinase-associated neurodegeneration patients [PDF]

open access: yesArchives of Biological Sciences, 2019
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by dystonia, parkinsonism, cognitive and visual impairment, and iron accumulation in the brain. Many cases of PKAN result from mutations in the PANK2
Svetel Marina   +7 more
doaj   +1 more source

Pantothenate kinase-associated neurodegeneration (PKAN) – a rare clinical entity [PDF]

open access: yesActa Oto-Laryngologica Case Reports, 2016
AbstractPantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder caused by the absence or deficiency of PANK 2 gene located on the chromosome 20p13-p12.3. This is a motor disorder of extrapyramidal type with dystonia, rigidity, involuntary movements (choreoathetosis or tremor) and other pyramidal signs.
Appas Saha, Srushti Shabnam, Swapna N
openaire   +1 more source

Enhanced Thermodynamic Stability of UO22+ Complex Through Structure Preorganization of N3O2‐Pentadentate Planar Ligand for Uranium Harvesting from Seawater

open access: yesAdvanced Science, Volume 13, Issue 17, 23 March 2026.
Thanks to the appropriate structure preorganization of an N3O2‐pentadentate planar ligand, 2,6‐bis(2‐hydroxyphenylmethylaminomethyl)pyridine (H2saldamp) exhibits the strongest coordination affinity to UO22+ (log βU = 33.60) compared to ligands developed for uranium harvesting from seawater to date, as well as good separability of UO22+ from other metal
Ryuto Nabata   +2 more
wiley   +1 more source

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments

open access: yesNeurology International, 2018
Pantothenate Kinase-Associated Neurodegeneration (PKAN) is an autosomal recessive disorder characterized by a mutation in the PANK2 gene. The clinical presentation may range from only speech disorder to severe generalized dystonia, spasticity, Visual ...
Saeed Razmeh   +5 more
doaj   +1 more source

The mean movement and disability scales in the patients with DYT-1 dystonia, PKAN, and tardive dystonia.

open access: yes, 2016
Patients with DYT-1 dystonia showed abrupt decrease in movement and disability scores over time. Patients with PKAN revealed relatively higher movement and disability scores preoperatively.
Gwanhee Ehm (844308)   +18 more
core   +1 more source

Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family

open access: yesHeliyon, 2021
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare hereditary neurodegenerative disease characterized by an accumulation of iron within the brain.
Ali S. Shalash   +8 more
doaj   +1 more source

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration [PDF]

open access: yesJournal of Movement Disorders, 2009
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder that is characterized by mutations in the pantothenate kinase 2 gene (PANK2) and typical magnetic resonance imaging findings.
Sung-Hyouk Kim   +6 more
doaj   +1 more source

Epidemiology of progressive intellectual and neurological deterioration in UK children

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 3, Page 418-428, March 2026.
This study of PIND in UK children was carried out via the British Paediatric Surveillance Unit from 1997 to 2024. It identified six cases of vCJD. 2367 children had other diagnoses explain their deterioration. There were 259 other diseases in the diagnosed group.
Christopher M. Verity   +3 more
wiley   +1 more source

Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients [PDF]

open access: yesContrast Media & Molecular Imaging, 2012
Iron deposits in the human brain can be considered as intrinsic contrast agents for magnetic resonance imaging and are used as markers of neurodegeneration accompanied by brain‐iron accumulation. We studied one of them – panthotenate‐kinase associated neurodegeneration (PKAN) – by using relaxometry at 1.5, 3.0 and 7 T in a group of six patients; we ...
Monika, Dezortova   +5 more
openaire   +2 more sources

Neurodegeneration with brain iron accumulation: A case report

open access: yesDementia & Neuropsychologia
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder caused by mutation in the PANK2 gene. It is characterized by abnormal brain iron accumulation, mainly in the globus pallidus.
Daniel Nassif   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy